NEUROPATHIX, INC. (NPTX) Financial Statements (2024 and earlier)
Company Profile
| Business Address |
3805 OLD EASTON ROAD DOYLESTOWN, PA 18902 |
| State of Incorp. | DE |
| Fiscal Year End | December 31 |
| Industry (SIC) | 2834 - Pharmaceutical Preparations (benchmarking) |
| More info | Complete Financial Analysis Financial Benchmarking |
Balance Sheet (Statement of Financial Position) ($ in thousands)
| 3/31/2022 MRQ | 12/31/2021 | 12/31/2020 | 12/31/2019 | 12/31/2018 | 12/31/2017 | 12/31/2016 | |||
|---|---|---|---|---|---|---|---|---|---|
| ASSETS | |||||||||
| Current Assets | |||||||||
| Cash, cash equivalents, and short-term investments | 16 | 22 | 121 | 2,887 | 2 | 0 | |||
| Cash and cash equivalents | 16 | 22 | 121 | 307 | 2 | 0 | |||
| Short-term investments | 2,580 | ||||||||
| Receivables | 10 | ||||||||
| Prepaid expense | 122 | 161 | 9 | ||||||
| Other undisclosed current assets | 0 | 0 | 0 | 116 | 0 | ||||
| Total current assets: | 138 | 183 | 131 | 3,003 | 2 | 10 | |||
| Noncurrent Assets | |||||||||
| Property, plant and equipment | 69 | 59 | 75 | 3 | |||||
| Deposits noncurrent assets | 17 | ||||||||
| Other undisclosed noncurrent assets | 17 | 17 | 17 | ||||||
| Total noncurrent assets: | 86 | 76 | 93 | 20 | |||||
| TOTAL ASSETS: | 225 | 260 | 223 | 3,023 | 2 | 10 | |||
| LIABILITIES AND EQUITY | |||||||||
| Liabilities | |||||||||
| Current Liabilities | |||||||||
| Accounts payable and accrued liabilities, including: | 800 | 721 | 389 | 284 | 1 | 17 | |||
| Interest and dividends payable | 0 | ||||||||
| Employee-related liabilities | 241 | 230 | 243 | ||||||
| Accounts payable | 195 | 128 | 1 | 17 | |||||
| Accrued liabilities | 530 | 379 | 243 | 246 | |||||
| Other undisclosed accounts payable and accrued liabilities | (167) | (16) | (97) | 38 | |||||
| Deferred revenue | 113 | ✕ | ✕ | ✕ | |||||
| Debt | 900 | 1,190 | 662 | 16 | 45 | ||||
| Derivative instruments and hedges, liabilities | 89 | 138 | 183 | ||||||
| Other liabilities | 5 | ||||||||
| Due to related parties | 47 | 55 | 25 | 20 | |||||
| Other undisclosed current liabilities | 1,034 | 441 | 67 | 246 | |||||
| Total current liabilities: | 2,983 | 2,546 | 1,327 | 546 | 51 | 36 | |||
| Noncurrent Liabilities | |||||||||
| Long-term debt and lease obligation | 108 | 446 | 379 | 26 | |||||
| Long-term debt, excluding current maturities | 108 | 446 | 379 | 26 | |||||
| Liabilities, other than long-term debt | 342 | 178 | 183 | ||||||
| Derivative instruments and hedges, liabilities | 342 | 178 | 183 | ||||||
| Other undisclosed noncurrent liabilities | 779 | 284 | 28 | 1,120 | |||||
| Total noncurrent liabilities: | 1,228 | 909 | 590 | 1,146 | |||||
| Total liabilities: | 4,211 | 3,454 | 1,917 | 1,692 | 51 | 36 | |||
| Equity | |||||||||
| Equity, attributable to parent, including: | (3,987) | (3,195) | (1,694) | 1,331 | (49) | (26) | |||
| Common stock | 9 | 8 | 7 | 7 | 1 | 1 | |||
| Additional paid in capital | 12,595 | 9,831 | 6,795 | 6,382 | 35 | 35 | |||
| Accumulated deficit | (16,591) | (13,033) | (8,496) | (5,052) | (85) | (62) | |||
| Other undisclosed equity, attributable to parent | (6) | ||||||||
| Total equity: | (3,987) | (3,195) | (1,694) | 1,331 | (49) | (26) | |||
| TOTAL LIABILITIES AND EQUITY: | 225 | 260 | 223 | 3,023 | 2 | 10 | |||
Income Statement (P&L) ($ in thousands)
| 3/31/2022 TTM | 12/31/2021 | 12/31/2020 | 12/31/2019 | 12/31/2018 | 12/31/2017 | 12/31/2016 | ||
|---|---|---|---|---|---|---|---|---|
| Revenues | 183 | 108 | 126 | 174 | 1 | 35 | ||
| Realized investment gains | 3,902 | |||||||
| Other income | 108 | |||||||
| Cost of revenue | (62) | (21) | ||||||
| Provision for loan, lease, and other losses | (62) | ✕ | ✕ | |||||
| Gross profit: | 183 | 108 | 126 | 112 | 1 | 14 | ||
| Operating expenses | (3,124) | (4,474) | (2,455) | (1,236) | (24) | (46) | ||
| Other undisclosed operating income (loss) | (108) | 62 | ||||||
| Operating loss: | (2,941) | (4,474) | (2,329) | (1,062) | (22) | (32) | ||
| Nonoperating income (expense) | (617) | (64) | (1,122) | 2,805 | ||||
| Interest and debt expense | (435) | (924) | (147) | |||||
| Income (loss) from continuing operations before equity method investments, income taxes: | (3,992) | (5,462) | (3,598) | 1,743 | (22) | (32) | ||
| Other undisclosed income from continuing operations before income taxes | 435 | 924 | 147 | |||||
| Income (loss) from continuing operations before income taxes: | (3,558) | (4,537) | (3,451) | 1,743 | (22) | (32) | ||
| Income tax expense | (812) | |||||||
| Income (loss) from continuing operations: | (3,558) | (4,537) | (3,451) | 931 | (22) | (32) | ||
| Income (loss) before gain (loss) on sale of properties: | ✕ | (3,558) | (4,537) | (3,451) | 931 | (22) | (32) | |
| Net income (loss): | (3,558) | (4,537) | (3,451) | 931 | (22) | (32) | ||
| Net income attributable to noncontrolling interest | 7 | 6 | ||||||
| Other undisclosed net loss attributable to parent | (7) | |||||||
| Net income (loss) attributable to parent: | (3,558) | (4,537) | (3,451) | 937 | (22) | (32) | ||
| Other undisclosed net income available to common stockholders, basic | 7 | |||||||
| Net income (loss) available to common stockholders, diluted: | (3,558) | (4,537) | (3,444) | 937 | (22) | (32) | ||
Comprehensive Income ($ in thousands)
| 3/31/2022 TTM | 12/31/2021 | 12/31/2020 | 12/31/2019 | 12/31/2018 | 12/31/2017 | 12/31/2016 | ||
|---|---|---|---|---|---|---|---|---|
| Net income (loss): | (3,558) | (4,537) | (3,451) | 931 | (22) | (32) | ||
| Comprehensive income (loss): | (3,558) | (4,537) | (3,451) | 931 | (22) | (32) | ||
| Comprehensive income, net of tax, attributable to noncontrolling interest | 7 | 6 | ||||||
| Comprehensive income (loss), net of tax, attributable to parent: | (3,558) | (4,537) | (3,444) | 937 | (22) | (32) | ||
Statements Sources
The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.